Complete remission of patients with heavily pretreated uterine sarcomas by weekly bevacizumab and temozolomide.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.11051
Abstract: 11051 Background: Uterine sarcomas are associated with poor prognosis snce the complete remission is extreme rare. Therefore, treatment with chemotherapy including eribulin or trabectedin, hormone therapy or molecular-targeted therapy including pazopanib or olaratumab was expectd,… read more here.
Keywords: uterine sarcomas; response; complete remission; heavily pretreated ... See more keywords